Intellectual Property India Publishes Patent Application for 'IL-18 Fusion Proteins And Methods Of Producing IL-18' Filed by Fuse Biotherapeutics Inc.

MUMBAI, India, Feb. 21 -- Intellectual Property India has published a patent application (202517008743 A) filed by Fuse Biotherapeutics Inc., Woburn, U.S.A., on Feb. 3, for 'il-18 fusion proteins and methods of producing il-18.'

Inventor(s) include Zhou, Xueyuan; Rabinovich, Brian; and Takimoto, Jeffrey.

The application for the patent was published on Feb. 21, under issue no. 08/2025.

According to the abstract released by the Intellectual Property India: "Fusion proteins are provided, which are composed of elements such as one or more proteins/polypeptides capable of translocating into an endoplasmic reticulum (ER) and an interleukin 18 (IL-18) or a fragment or variant of IL-18. The proteins/polypeptides capable of translocating into the...